Smartphone app aims to boost breast cancer treatment adherence

NCT ID NCT04554927

Ongoing Disease control Sponsor: Centre Francois Baclesse Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a web application can help breast cancer patients take their hormone therapy as prescribed. About 438 patients starting hormone therapy will either use the app or receive standard care. The goal is to see if the app improves medication adherence and quality of life over 18 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: web application
What this could lead to: If it works, this could show that a simple web app helps breast cancer patients take their hormone therapy more consistently, potentially improving treatment outcomes.
What could go wrong: This is a relatively small, single-center trial testing a behavioral intervention, not a new drug. The app may not significantly improve adherence, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER HORMONO THERAPY WEB-APPLICATION

Contacts and locations

Locations

Centre François baclesse

Caen, 14000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.